Live Breaking News & Updates on நிதி கருவிகள் சந்தை

Stay updated with breaking news from நிதி கருவிகள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Opinion of the Management Board of JSC Olainfarm on the offer of mandatory share buy-back of the company and its impact on the public interest

Opinion of the Management Board of JSC Olainfarm on the offer of mandatory share buy-back of the company and its impact on the public interest
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Janis Dubrovskis , Management Board Of The Company , Capital Market Commission , Management Board , Financial Instruments Market , Relations Advisor , மேலாண்மை பலகை ஆஃப் தி நிறுவனம் , மூலதனம் சந்தை தரகு , மேலாண்மை பலகை , நிதி கருவிகள் சந்தை ,

Investegate |Olainfarm Announcements | Olainfarm: Information expressed in the public domain by the Repharm Group is deceptive and contradictory


Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from Repharm Group will acquire the shares of JSC “Olainfarm” directly and indirectly owned by Anna Emilija Maligina.
The Chairman of the Management Board of JSC Olainfarm Jeroen Weites points out that  Signe Baldere - Sildedze, the legal representative of Anna Emilija Maligina, has informed the Board of JSC Olainfarm that the information in the public domain is false and the deal entered with SIA Farma Fund (previous name Zdorovie Europe) is not valid. Consequently, there is no basis for Repharm group to make such a statement. ....

Anna Emilija Maligina , Diamed Olainmed , Signe Baldere , Olainfarm Jeroen Weites , Baltic States , Zdorovie Europe , Farma Fund , Capital Market Commission , Repharm Group , Olainfarm Group , Anna Emilija , Management Board , Jeroen Weites , Financial Instruments Market Law , Financial Instruments Market , Eastern European , Tonus Elast , Relations Advisor , பால்டிக் மாநிலங்களில் , பண்ணை நிதி , மூலதனம் சந்தை தரகு , மேலாண்மை பலகை , நிதி கருவிகள் சந்தை சட்டம் , நிதி கருவிகள் சந்தை , கிழக்கு ஐரோப்பிய ,

Olainfarm: Information expressed in the public domain by the Repharm Group is deceptive and contradictory


Olainfarm: Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from Repharm Group will acquire the shares of JSC Olainfarm directly and indirectly owned by Anna Emilija Maligina.
The Chairman of the Management Board of JSC Olainfarm Jeroen Weites points out that Signe Baldere - Sildedze, the legal representative of Anna Emilija Maligina, has informed the Board of JSC Olainfarm that the information in the public domain is false and the deal entered with SIA Farma Fund (previous name Zdorovie Europe) is not valid. Consequently, there is no basis for Repharm group to make such a statement. ....

Anna Emilija Maligina , Diamed Olainmed , Signe Baldere , Olainfarm Jeroen Weites , Baltic States , Janis Dubrovskis , Zdorovie Europe , Farma Fund , Capital Market Commission , Repharm Group , Olainfarm Group , Anna Emilija , Management Board , Jeroen Weites , Financial Instruments Market Law , Financial Instruments Market , Eastern European , Tonus Elast , Relations Advisor , பால்டிக் மாநிலங்களில் , பண்ணை நிதி , மூலதனம் சந்தை தரகு , மேலாண்மை பலகை , நிதி கருவிகள் சந்தை சட்டம் , நிதி கருவிகள் சந்தை , கிழக்கு ஐரோப்பிய ,